## GEV: GE Vernova Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.2% below STRENGTH zone (4.0-10.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($543.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Level Four Advisory Services LLC Reduces Stock Position in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251130T113448 | Neutral | Relevance: 98%
- Level Four Advisory Services LLC significantly reduced its stake in GE Vernova Inc. by 56.9% during the second quarter, selling 4,043 shares and owning 3,057 shares worth $1,618,000. Despite this, several other institutional investors like Vanguard Group Inc. and Geode Capital Management LLC increased their positions in the company, while analyst ratings range from "Strong Buy" to "Sell" with a consensus "Moderate Buy". GE Vernova reported mixed Q3 earnings, missing EPS estimates but exceeding revenue forecasts, and declared a quarterly dividend of $0.25 per share.

**2. Lumbard & Kellner LLC Invests $274,000 in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251201T121835 | Somewhat-Bullish | Relevance: 98%
- Lumbard & Kellner LLC has acquired a new stake of $274,000 in GE Vernova Inc. (NYSE:GEV), purchasing 517 shares in the second quarter. This investment is part of a broader trend of institutional interest in GE Vernova, with several other firms also significantly increasing their positions. The article further details GE Vernova's financial performance, stock metrics, and recent analyst ratings, which predominantly recommend a "Buy" for the stock.

**3. GE Vernova Inc. $GEV Shares Sold by VestGen Advisors LLC**
- Source: MarketBeat | 20251201T131141 | Neutral | Relevance: 98%
-  VestGen Advisors LLC trimmed its stake in GE Vernova Inc. by 11.8% in the second quarter, selling 615 shares and retaining 4,596 shares valued at approximately $2.49 million. Other institutional investors also adjusted their positions modestly. Analyst sentiment toward GEV is mixed but generally positive, with a consensus "Moderate Buy" rating and a target price of $607.81, despite recent EPS misses and revenue beats.

**4. Pinkerton Wealth LLC Makes New $2.88 Million Investment in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251202T133111 | Somewhat-Bullish | Relevance: 98%
-  Pinkerton Wealth LLC has made a new $2.88 million investment in GE Vernova Inc. ($GEV), acquiring 5,450 shares in Q2. This new investment, alongside significant holdings by other institutional investors like Vanguard Group Inc. and Norges Bank, indicates growing confidence in GE Vernova. The stock currently holds a "Moderate Buy" consensus rating with an average target price of $607.81, despite a recent EPS miss but a beat on revenue.

**5. General Electric shareholders – who owns the most GE stock?**
- Source: Capital.com | 20251201T213654 | Neutral | Relevance: 95%
- This article details the ownership structure of General Electric's three independent entities—GE Aerospace, GE Vernova, and GE HealthCare Technologies—following its three-way split. It highlights how institutional investors, particularly mutual funds and ETFs, hold the majority of shares across all three companies, with Capital Research and Management Company, Vanguard, and BlackRock being prominent large shareholders. The article also touches on insider ownership, with H. Lawrence Culp Jr. being a key insider shareholder.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $855 | $0 | 0% |
| 2025-12-10 | UBS | $835 | $760 | +10% |
| 2025-12-10 | Susquehanna | $775 | $750 | +3% |
| 2025-12-10 | BMO Capital | $780 | $710 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | up | Outperform |
| 2025-12-10 | UBS | main | Buy |
| 2025-12-10 | Susquehanna | main | Positive |
| 2025-12-10 | BMO Capital | main | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.6%)
- FMR, LLC: 8.4% (-8.5%)
- Blackrock Inc.: 7.4% (+1.8%)
- JPMORGAN CHASE & CO: 4.2% (+641.6%)
- State Street Corpora: 4.1% (+1.3%)

### Key Risks

1. High beta (2.11) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +7%) could attract flows.
- Momentum building: MRS_20 improving +2.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 46.1x attractive for 68% earnings growth. Analyst sentiment positive (5 raises, avg +7%). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $196.8B |
| Beta | 1.00 |
| 52W Range | $252.25 - $731.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 46.1 |
| Current P/E | 77.6 |
| YoY Growth | 68.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 0.7% to 3.2% (+2.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 5.0% shows strong absolute momentum above own 20MA. Outperforming sector by 4.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.30), confirming momentum. RSI neutral at 55.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.16% (CS: 84) | Neutral |
| RSI_14 | 54.8 | Neutral |
| MACD Histogram | 4.30 | Bullish |
| vs SMA20 | 1.050x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.202x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $601.58
- **Stop Loss:** $543.02 (9.7% risk)
- **Target:** $660.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 8
- **Position Value:** $4,812.64
- **Portfolio %:** 4.81%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-21 (Est: $3.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.86 | $1.64 | -11.7% |
| 2025Q2 | $1.63 | $1.86 | +14.3% |
| 2025Q1 | $0.61 | $0.91 | +49.1% |
| 2024Q4 | $2.49 | $1.73 | -30.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*